{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:40:14Z","timestamp":1759174814369,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.diabres.2023.110796","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T19:14:19Z","timestamp":1687461259000},"page":"110796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016\u20132018"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-6968","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-7562","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-8387","authenticated-orcid":false,"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.diabres.2023.110796_b0005","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.110796_b0010","unstructured":"IDF Diabetes Atlas 2021 (10th edition). http:\/\/www.diabetesatlas.org\/."},{"issue":"12","key":"10.1016\/j.diabres.2023.110796_b0015","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.diabres.2023.110796_b0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005\u20132008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.diabres.2023.110796_b0025","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2023.110796_b0030","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4103\/ijo.IJO_1237_21","article-title":"Clinical correlation of diabetic retinopathy with nephropathy and neuropathy","volume":"69","author":"Saini","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110796_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-9-12","article-title":"Prevalence of diabetic retinopathy in Tehran province: a population-based study","volume":"9","author":"Javadi","year":"2009","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110796_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-5859-x","article-title":"Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil","volume":"18","author":"Melo","year":"2018","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.diabres.2023.110796_b0045","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.diabres.2023.110796_b0050","first-page":"3","article-title":"Diabetic retinopathy in the Asia-Pacific","volume":"7","author":"Chua","year":"2018","journal-title":"Asia-Pac J Ophthalmol"},{"key":"10.1016\/j.diabres.2023.110796_b0055","first-page":"64","article-title":"Diabetic retinopathy in Asia","author":"Meyer","year":"2005","journal-title":"Cataract Refract Surg Today"},{"issue":"12","key":"10.1016\/j.diabres.2023.110796_b0060","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1016\/S2468-2667(20)30254-1","article-title":"Prevalence and causes of vision loss in China from 1990 to 2019: findings from the global burden of disease study 2019","volume":"5","author":"Xu","year":"2020","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.diabres.2023.110796_b0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2023.110796_b0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1464-5491.2012.03756.x","article-title":"Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review","volume":"30","author":"Burgess","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110796_b0075","doi-asserted-by":"crossref","unstructured":"Cui J, Ren JP, Chen DN, et al. Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study. BMJ Open 2017;7:e015473. doi: 10.1136\/bmjopen-2016-015473.","DOI":"10.1136\/bmjopen-2016-015473"},{"issue":"4","key":"10.1016\/j.diabres.2023.110796_b0080","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1111\/j.1755-3768.2010.02062.x","article-title":"Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study","volume":"89","author":"Wang","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.diabres.2023.110796_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10792-008-9272-9","article-title":"Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001","volume":"29","author":"Xie","year":"2009","journal-title":"Int Ophthalmol"},{"issue":"11","key":"10.1016\/j.diabres.2023.110796_b0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00417-008-0884-6","article-title":"Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006","volume":"246","author":"Xie","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110796_b0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/112067210901900114","article-title":"Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study","volume":"19","author":"Xie","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.diabres.2023.110796_b0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy:a systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.diabres.2023.110796_b0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1755-3768.2008.01298.x","article-title":"Association between serum lipoprotein(a) level and progression of non\u2014proliferative diabetic retinopathy in Type 2 diabetes","volume":"87","author":"Funatsu","year":"2009","journal-title":"Aeta Ophthalmologica"},{"key":"10.1016\/j.diabres.2023.110796_b0110","first-page":"225","article-title":"Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: a hospital based study","volume":"9","author":"Shrestha","year":"2007","journal-title":"Nepal Med Coll J"},{"issue":"4","key":"10.1016\/j.diabres.2023.110796_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2023.110796_b0120","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4103\/jfmpc.jfmpc_231_20","article-title":"A clinical study of the association and risk factors for lower limb neuropathy in patients with diabetic retinopathy","volume":"9","author":"Joshi","year":"2020","journal-title":"J Family Med Primary Care"},{"issue":"supplement1","key":"10.1016\/j.diabres.2023.110796_b0125","doi-asserted-by":"crossref","first-page":"s658","DOI":"10.4103\/jpbs.jpbs_138_22","article-title":"Correlation between diabetic retinopathy and diabetic peripheral neuropathy in patients with type II diabetes mellitus","volume":"14","author":"Hafeez","year":"2022","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.diabres.2023.110796_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.dsx.2012.09.002","article-title":"Explorative study on diabetic neuropathy among type 2 diabetic patients in university Sains Malaysia Hospital","volume":"6","author":"Salwa","year":"2012","journal-title":"Diabetic Metab Synd: Clin Res Rev"},{"key":"10.1016\/j.diabres.2023.110796_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-5996-4-21","article-title":"The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country","volume":"4","author":"Katulanda","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabres.2023.110796_b0140","first-page":"e21927","article-title":"Correlation of albuminuria and diabetic retinopathy in type-II diabetes mellitus","volume":"14","author":"Dash","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.diabres.2023.110796_b0145","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.dsx.2020.08.026","article-title":"Relationship between diabetic retinopathy and diabetic nephropathy; a longitudinal follow-up study from a tertiary care unit of Karachi, Pakistan","volume":"14","author":"Butt","year":"2020","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"issue":"8","key":"10.1016\/j.diabres.2023.110796_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161897","article-title":"Diabetic retinopathy in patients with diabetic nephropathy: development and progression","volume":"11","author":"Jeng","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.diabres.2023.110796_b0155","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2147\/DMSO.S378500","article-title":"The prevalence and risk factors of diabetic retinopathy: screening and prophylaxis project in 6 provinces of China","volume":"15","author":"Liu","year":"2022","journal-title":"Diabetes Metab Syndr Obes: Targets Ther"},{"key":"10.1016\/j.diabres.2023.110796_b0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4093\/dmj.2018.0047","article-title":"The prevalence and risk factors for diabetic retinopathy in Shiraz, Southern Iran","volume":"42","author":"Ghaem","year":"2018","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2023.110796_b0165","first-page":"209","article-title":"Diabetic retinopathy epidemiology in type II diabetic patients: effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy","volume":"82","author":"Romero-Aroca","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"Suppl 4","key":"10.1016\/j.diabres.2023.110796_b0170","first-page":"S43","article-title":"Prevalence and associated factors of diabetic retinopathy in Chandrubeksa Hospital, Directorate of Medical Services, Royal Thai Air Force","volume":"95","author":"Silpa-Archa","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.diabres.2023.110796_b0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-0420.2004.00270.x","article-title":"The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark","volume":"82","author":"Hove","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.diabres.2023.110796_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI0213776","article-title":"Acute intensive insulin therapy exacerbates diabetic blood\u2014retinal barrier breakdown via hypoxia-inducible factor-1\u03b1 and VEGF","volume":"109","author":"Pulaki","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2023.110796_b0185","article-title":"Does insulin like growth facto-l (IGF-1) deficiency have a \u201cprotective\u201d role in the development of diabetic retinopathy in Thalassamia major patients","volume":"7","author":"De Sanetis","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.diabres.2023.110796_b0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1746-1596-9-130","article-title":"Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies","volume":"9","author":"Zhao","year":"2014","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110796_b0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdiacomp.2008.03.001","article-title":"Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus","volume":"23","author":"Tam","year":"2009","journal-title":"J Diabetes Compl"},{"issue":"6","key":"10.1016\/j.diabres.2023.110796_b0200","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.2003.00972.x","article-title":"The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study","volume":"20","author":"Clarke","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110796_b0205","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110796_b0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00417-007-0573-x","article-title":"The economic burden of diabetic retinopathy in Germany in 2002","volume":"246","author":"Happich","year":"2007","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.diabres.2023.110796_b0215","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00125-010-1836-3","article-title":"Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden","volume":"53","author":"Heintz","year":"2010","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.diabres.2023.110796_b0220","article-title":"Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.diabres.2023.110796_b0225","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diacare.17.8.909","article-title":"Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform","volume":"17","author":"Javitt","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110796_b0230","first-page":"200","article-title":"The prevalence and related direct medical costs of chronic complications among patients with type 2 diabetes in China","volume":"35","author":"He","year":"2019","journal-title":"Chin J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2023.110796_b0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1753-0407.12165","article-title":"China Type 2 diabetes treatment status survey of treatment pattern of oral drugs users","volume":"7","author":"Ji","year":"2015","journal-title":"J Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2023.110796_b0240","first-page":"484","article-title":"Pharmacologic management of type 2 diabetes: 2016 interim update","volume":"40","author":"Booth","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2023.110796_b0245","doi-asserted-by":"crossref","unstructured":"The Professional Practice Committee of the American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1\u2013S104. doi: 10.2337\/dc17-S0011.","DOI":"10.2337\/dc17-0299"},{"key":"10.1016\/j.diabres.2023.110796_b0250","doi-asserted-by":"crossref","unstructured":"The Professional Practice Committee of the American Diabetes Association. Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41(Suppl. 1):S1. doi: 10.2337\/dc18-S008.","DOI":"10.2337\/dc18-S015"},{"issue":"12","key":"10.1016\/j.diabres.2023.110796_b0255","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2023.110796_b0260","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy: a systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2023.110796_b0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lfs.2019.02.023","article-title":"Calcium dobesilate and micro-vascular diseases","volume":"221","author":"Liu","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2023.110796_b0270","first-page":"241","article-title":"Expert consensus on prevention and treatment of diabetic retinopathy","volume":"10","year":"2018","journal-title":"Chin J Diabetes Mellitus"},{"key":"10.1016\/j.diabres.2023.110796_b0275","doi-asserted-by":"crossref","unstructured":"Liu WY, Hsu CH, Liu TJ, Chen PE, Zheng B, Chien CW, et al. Systematic review of the effect of a zero-markup policy for essential drugs on healthcare costs and utilization in China, 2015\u20132021. Front Med 20218:618046. doi: 10.3389\/ fmed.2021.618046.","DOI":"10.3389\/fmed.2021.618046"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723005594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723005594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:27:07Z","timestamp":1759174027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723005594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":55,"alternative-id":["S0168822723005594"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110796","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016\u20132018","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110796"}}